Recent Price Performance and Market Comparison
Oriental Aromatics has experienced a notable decline over multiple time frames. In the past week, the stock fell by 6.35%, contrasting sharply with the Sensex’s modest gain of 0.87%. This negative trend extends over longer periods, with the stock down 17.60% in one month and 25.70% year-to-date, while the Sensex has advanced by 2.03% and 9.60% respectively. Over the last year, the stock’s decline deepened to 36.07%, starkly underperforming the Sensex’s 7.32% rise. Even over three and five years, Oriental Aromatics has lagged significantly, with losses of 33.76% and 49.28%, compared to Sensex gains of 35.33% and 91.78%.
On 01-Dec, the stock underperformed its sector by 1.92%, continuing a losing streak that has lasted eight consecutive trading days, during which it has shed 10.73% in value. Intraday, the share price touched a low of ₹302, down 3.22%, with heavier trading volumes concentrated near this low point, signalling selling pressure. The stock is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating a sustained bearish trend.
Investor participation has also waned, with delivery volumes on 28 Nov falling by 35.65% compared to the five-day average, suggesting reduced conviction among shareholders. Despite adequate liquidity for sizeable trades, the stock’s downward momentum remains unbroken.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Fundamental Weaknesses Driving the Decline
Despite an attractive valuation indicated by a Return on Capital Employed (ROCE) of 4.5% and an enterprise value to capital employed ratio of 1.3, Oriental Aromatics’ fundamentals have deteriorated sharply. The company’s profitability has been under severe pressure, with profits falling by 74.5% over the past year. This erosion in earnings power is reflected in the stock’s poor returns and investor sentiment.
Long-term financial health is also concerning. Operating profits have contracted at a compound annual growth rate (CAGR) of -15.52% over the last five years, signalling sustained operational challenges. The average Return on Equity (ROE) stands at a low 5.75%, indicating limited profitability generated from shareholders’ funds. This weak profitability profile undermines investor confidence and contributes to the stock’s persistent decline.
The company has reported negative results for three consecutive quarters, including the latest quarter ending March 2025, marking four straight quarters of losses. The latest six-month Profit After Tax (PAT) was a mere ₹1.24 crore, down by 95.19%, while operating cash flow for the year plunged to a negative ₹34.29 crore. Additionally, the operating profit to interest coverage ratio has fallen to a low of 1.77 times, highlighting increased financial strain.
Investor interest from institutional players appears minimal, with domestic mutual funds holding no stake in the company. Given their capacity for thorough research, this absence may reflect concerns about the company’s valuation or business prospects.
Is Oriental Aromat. your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Conclusion: Why the Stock Is Falling
Oriental Aromatics’ share price decline is primarily driven by its weak financial performance and deteriorating fundamentals. The company’s sustained losses, declining profitability, and poor operating cash flows have eroded investor confidence. Its consistent underperformance relative to the Sensex and sector peers further compounds negative sentiment. The lack of institutional backing and falling investor participation underscore the challenges the stock faces in regaining momentum.
While the stock trades at a discount to peers, this valuation advantage has not translated into positive returns due to the company’s operational struggles and disappointing earnings trajectory. Until there is a clear turnaround in profitability and cash flow generation, the stock is likely to remain under pressure.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
